Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer (VOXEL)

This study has been terminated.
(Recruitment rate to low; changed environment made protocol in its current state obsolete)
Sponsor:
Collaborator:
iOMEDICO AG
Information provided by (Responsible Party):
AIO-Studien-gGmbH
ClinicalTrials.gov Identifier:
NCT00950820
First received: July 31, 2009
Last updated: March 1, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2012
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)